Shilpa Medicare Limited
Precision Medicine
Innovation

Specialized Payload, Linker & Intermediate Capabilities for Next-Generation ADCs

Advanced pharmaceutical solutions

Targeted • Precise • Effective

Learn more about our adc payloads, linkers & intermediates | shilpa pharma services and capabilities.

Peptides
Custom synthesis
Polymers
Drug delivery
ADCs
Targeted therapy
Specialized Payload, Linker & Intermediate Capabilities for Next-Generation ADCs
1000+
Peptides Synthesized
50+
Polymer Types
200+
ADC Projects
99.5%
Purity Standard

Specialized Payload, Linker & Intermediate Capabilities for Next-Generation ADCs

A successful ADC starts with the right payload-linker design. We bring deep synthetic chemistry expertise and a broad payload portfolio to support diverse ADC platforms — including highly potent cytotoxics and emerging warhead classes.

Payload Expertise

Payload Portfolio

  • • MMAE
  • • MMAF
  • • DM1
  • • Maytansine
  • • Dolastatin
  • • Tubulysin
  • • Amanitin
  • • Tesirine
  • • PBD

Linker Technologies

  • • Peptide-based linkers
  • • PEG-based linkers
  • • Cleavable linkers
  • • Non-cleavable linkers
  • • Custom linker design & synthesis

Chemistry Expertise

  • • Amino acid protection chemistry
  • • Orthogonal protection strategies
  • • Ester, carbamate & carbonate chemistry
  • • Complex multi-step synthesis

Integrated ADC Platform

Our payload and linker capabilities are part of a fully integrated ADC platform — combining payloads, linkers, conjugation, analytics, and GMP manufacturing under one roof. Start a conversation with our ADC team today.

Contact Us